Month: November 2017
-
Biotech Licenses Mayo Clinic Microbiome Research
A biotechnology company developing therapies with specialized gut microbes is licensing research from the Mayo Clinic on these microbes’ effects with autoimmune diseases.
-
Report: Health System Not Ready for Alzheimer’s Therapies
A new study finds the U.S. health care system does not have the capacity for large-scale screening and treatment of people with early indicators of Alzheimer’s disease.
-
Trial Underway Testing Personal RNA Cancer Drug
A clinical trial is underway testing a treatment for solid tumor cancers derived from messenger RNA, genetic material with protein coding instructions for cells.
-
Two Opioid Addiction Treatments Found Safe, Effective
A clinical trial testing two leading therapies for opioid abuse found the treatments both safe and effective, even though they work in different ways.
-
Helping Your IT Brand Become a Mighty Brand
You have to develop a strong company identity that’ll make them choose you. Here’s some advice on how to turn your IT brand into a mighty brand.
-
Alliance Exploring Microbiome on Cancer Immunotherapy
A biotechnology company and two research institutes are collaborating on a study of a proposed cancer treatment that targets the microbiome, communities of bacteria in the human body.
-
FDA Clears First Sensor-Pill and App System
The Food and Drug Administration approved for the first time in the U.S. a system that combines pills with built-in sensors and a mobile app to track adherence.
-
Zymeworks, Janssen in $1.45B Antibody Licensing Deal
Janssen Biotech, a division of drug maker Johnson & Johnson, is acquiring technologies that make it possible to create synthetic antibodies that hit multiple targets.
-
Infographic: Largest Hacker Breaches and Regulation Tech
Among the most visible and challenging regulatory issues for companies is security breaches, where companies’ systems are attacked with valuable data stolen.
-
Math Models to Predict Animal-Borne Disease Outbreaks
A team of ecologists and mathematicians is applying machine learning and statistical models to forecast outbreaks of zoonotic diseases, those spread to humans from animals.